"UK Scientists Develop Groundbreaking Lung Cancer Vaccine Using DNA Technology"

Scientists in the UK have been granted funding to develop the world's first lung cancer vaccine, called LungVax, using technology similar to the Oxford/AstraZeneca COVID vaccine. The vaccine aims to train the immune system to recognize and attack cancer cells, potentially saving thousands of lives. If successful, the project could lead to a significant advancement in preventing lung cancer, which is the leading cause of cancer death in the EU, with cigarette smoking being the largest risk factor.